Harrow Health, Inc. 8.625% Senior Notes due 2026
Harrow Health, Inc. 8.625% Senior Notes due 2026 HROWL Peers
See (HROWL) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HROWL | $25.29 | +0.03% | 964.39M | N/A | N/A | N/A |
| INSM | $65.61 | -0.15% | 11.95B | -11.06 | -$5.93 | N/A |
| WBA | $11.13 | -2.11% | 9.62B | -1.66 | -$6.69 | +6.70% |
| ONC | $219.95 | -2.13% | 1.68B | -60.43 | -$3.64 | N/A |
| LFMDP | $24.50 | -1.61% | 1.11B | -10.86 | -$2.26 | N/A |
| HROWM | $26.55 | -0.23% | 974.37M | N/A | N/A | +11.15% |
| LFMD | $9.56 | +12.21% | 434.48M | -28.97 | -$0.33 | N/A |
| HITI | $2.35 | +2.62% | 190.21M | -39.17 | -$0.06 | N/A |
| PETS | $3.78 | -3.57% | 78.08M | 378.00 | $0.01 | N/A |
| YI | $7.61 | -3.67% | 65.96M | -7.25 | -$1.05 | N/A |
Stock Comparison
HROWL vs INSM Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, INSM has a market cap of 11.95B. Regarding current trading prices, HROWL is priced at $25.29, while INSM trades at $65.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas INSM's P/E ratio is -11.06. In terms of profitability, HROWL's ROE is -0.36%, compared to INSM's ROE of -4.47%. Regarding short-term risk, HROWL is less volatile compared to INSM. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs WBA Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, WBA has a market cap of 9.62B. Regarding current trading prices, HROWL is priced at $25.29, while WBA trades at $11.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas WBA's P/E ratio is -1.66. In terms of profitability, HROWL's ROE is -0.36%, compared to WBA's ROE of -0.55%. Regarding short-term risk, HROWL is less volatile compared to WBA. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs ONC Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, ONC has a market cap of 1.68B. Regarding current trading prices, HROWL is priced at $25.29, while ONC trades at $219.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas ONC's P/E ratio is -60.43. In terms of profitability, HROWL's ROE is -0.36%, compared to ONC's ROE of -0.19%. Regarding short-term risk, HROWL is less volatile compared to ONC. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs LFMDP Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, LFMDP has a market cap of 1.11B. Regarding current trading prices, HROWL is priced at $25.29, while LFMDP trades at $24.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas LFMDP's P/E ratio is -10.86. In terms of profitability, HROWL's ROE is -0.36%, compared to LFMDP's ROE of +2.33%. Regarding short-term risk, HROWL is more volatile compared to LFMDP. This indicates potentially higher risk in terms of short-term price fluctuations for HROWL.
HROWL vs HROWM Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, HROWM has a market cap of 974.37M. Regarding current trading prices, HROWL is priced at $25.29, while HROWM trades at $26.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas HROWM's P/E ratio is N/A. In terms of profitability, HROWL's ROE is -0.36%, compared to HROWM's ROE of -0.28%. Regarding short-term risk, HROWL is less volatile compared to HROWM. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs LFMD Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, LFMD has a market cap of 434.48M. Regarding current trading prices, HROWL is priced at $25.29, while LFMD trades at $9.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas LFMD's P/E ratio is -28.97. In terms of profitability, HROWL's ROE is -0.36%, compared to LFMD's ROE of +2.33%. Regarding short-term risk, HROWL is less volatile compared to LFMD. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs HITI Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, HITI has a market cap of 190.21M. Regarding current trading prices, HROWL is priced at $25.29, while HITI trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas HITI's P/E ratio is -39.17. In terms of profitability, HROWL's ROE is -0.36%, compared to HITI's ROE of -0.05%. Regarding short-term risk, HROWL is less volatile compared to HITI. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs PETS Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, PETS has a market cap of 78.08M. Regarding current trading prices, HROWL is priced at $25.29, while PETS trades at $3.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas PETS's P/E ratio is 378.00. In terms of profitability, HROWL's ROE is -0.36%, compared to PETS's ROE of +0.00%. Regarding short-term risk, HROWL is less volatile compared to PETS. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs YI Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, YI has a market cap of 65.96M. Regarding current trading prices, HROWL is priced at $25.29, while YI trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas YI's P/E ratio is -7.25. In terms of profitability, HROWL's ROE is -0.36%, compared to YI's ROE of +0.10%. Regarding short-term risk, HROWL is less volatile compared to YI. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs RNTX Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, RNTX has a market cap of 49.48M. Regarding current trading prices, HROWL is priced at $25.29, while RNTX trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas RNTX's P/E ratio is -0.64. In terms of profitability, HROWL's ROE is -0.36%, compared to RNTX's ROE of -0.80%. Regarding short-term risk, HROWL is less volatile compared to RNTX. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs RAD Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, RAD has a market cap of 36.76M. Regarding current trading prices, HROWL is priced at $25.29, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas RAD's P/E ratio is -0.05. In terms of profitability, HROWL's ROE is -0.36%, compared to RAD's ROE of +0.91%. Regarding short-term risk, HROWL is less volatile compared to RAD. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs MEDS Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, MEDS has a market cap of 13.28M. Regarding current trading prices, HROWL is priced at $25.29, while MEDS trades at $7.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas MEDS's P/E ratio is -0.31. In terms of profitability, HROWL's ROE is -0.36%, compared to MEDS's ROE of +0.22%. Regarding short-term risk, HROWL is less volatile compared to MEDS. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs CJJD Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, CJJD has a market cap of 9.95M. Regarding current trading prices, HROWL is priced at $25.29, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas CJJD's P/E ratio is -0.46. In terms of profitability, HROWL's ROE is -0.36%, compared to CJJD's ROE of -0.30%. Regarding short-term risk, HROWL is less volatile compared to CJJD. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs NEUP Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, NEUP has a market cap of 8.59M. Regarding current trading prices, HROWL is priced at $25.29, while NEUP trades at $4.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas NEUP's P/E ratio is 0.45. In terms of profitability, HROWL's ROE is -0.36%, compared to NEUP's ROE of -0.43%. Regarding short-term risk, HROWL is less volatile compared to NEUP. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs ATNFW Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, ATNFW has a market cap of 6.06M. Regarding current trading prices, HROWL is priced at $25.29, while ATNFW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas ATNFW's P/E ratio is N/A. In terms of profitability, HROWL's ROE is -0.36%, compared to ATNFW's ROE of -2.12%. Regarding short-term risk, HROWL is less volatile compared to ATNFW. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs SSY Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, SSY has a market cap of 5.90M. Regarding current trading prices, HROWL is priced at $25.29, while SSY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas SSY's P/E ratio is -1.99. In terms of profitability, HROWL's ROE is -0.36%, compared to SSY's ROE of +0.12%. Regarding short-term risk, HROWL is less volatile compared to SSY. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs MDVL Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, MDVL has a market cap of 2.91M. Regarding current trading prices, HROWL is priced at $25.29, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas MDVL's P/E ratio is -0.05. In terms of profitability, HROWL's ROE is -0.36%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, HROWL is less volatile compared to MDVL. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs LFLYW Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, LFLYW has a market cap of 938547.00. Regarding current trading prices, HROWL is priced at $25.29, while LFLYW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas LFLYW's P/E ratio is -0.06. In terms of profitability, HROWL's ROE is -0.36%, compared to LFLYW's ROE of +0.39%. Regarding short-term risk, HROWL is more volatile compared to LFLYW. This indicates potentially higher risk in terms of short-term price fluctuations for HROWL.
HROWL vs LFLY Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, LFLY has a market cap of 781966.00. Regarding current trading prices, HROWL is priced at $25.29, while LFLY trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas LFLY's P/E ratio is -0.11. In terms of profitability, HROWL's ROE is -0.36%, compared to LFLY's ROE of +0.39%. Regarding short-term risk, HROWL is less volatile compared to LFLY. This indicates potentially lower risk in terms of short-term price fluctuations for HROWL.
HROWL vs BIMI Comparison
HROWL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HROWL stands at 964.39M. In comparison, BIMI has a market cap of 9423.00. Regarding current trading prices, HROWL is priced at $25.29, while BIMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HROWL currently has a P/E ratio of N/A, whereas BIMI's P/E ratio is N/A. In terms of profitability, HROWL's ROE is -0.36%, compared to BIMI's ROE of -2.93%. Regarding short-term risk, HROWL is more volatile compared to BIMI. This indicates potentially higher risk in terms of short-term price fluctuations for HROWL.